FMI Research Report and Overview on Near-Patient Molec | Page 4

Near-Patient Molecular Solutions Market
Near-Patient Molecular Solutions Market Globally Expected to Drive Growth through 2026
Innovations in healthcare technologies, including smartphone apps, wearable devices, lab-on-a chip, biosensors
all of which offer easy link to the patient quickly becoming part of the transformation of the healthcare
landscape. The driving concept in support of point of care diagnostic is to bring testing closer to the patient and
provide results appropriately and quickly. This is different technique than earlier used where all the tests were
performed in the laboratory.Point of care testing has extensive application base that includes, oncology,
hematology, endocrinology, prenatal testing and near patient testing in infectious disease management. Most
substantial progress have taken place in the fields of oncology point of care molecular tests and infectious
diseases.Rapid flu testing is a leading application for point of care platforms.
Near-Patient Molecular SolutionsMarket: Drivers and Restraints
Factors, such as the increasing incidences of diseases such as cardiac diseases and diabetes in developing
countries, increase in the usage of home-based point of care devices, and advancement in technology with
demand for development of faster and easy to use devices are energizing the point of care diagnostic market.
Rising demand for home healthcare facility and the increment in population of elderly patients with multiple
chronic conditions is expecte d to drive point of care diagnostics market over the forecast period. In light of the
many factors increasing the demand for point of care diagnosis, manufacturing companies are pushing the
envelope to make point of care devices faster, easier, and more reliable. Shortage of skilled-staff, especially in
the field of diagnostics, are expected to restrain the market growth for point of care diagnostic.

©2015 Future Market Insights, All Rights Reserved

4